Page values for "Ticagrelor"
From Pharmacopedia
More actions
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Ticagrelor |
| brand | String | Brilinta |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Antiplatelet_agents|Antiplatelet agent]] • [[:Category:P2Y12_inhibitors|P2Y12 receptor inhibitor (reversible)]] • [[:Category:Cyclopentyltriazolopyrimidines|Cyclopentyltriazolopyrimidine]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000C8F-QINU`"', '"`UNIQ--vote-00000C90-QINU`"', '"`UNIQ--vote-00000C91-QINU`"' |
| starting_dose | String | ACS/PCI: 180 mg PO loading dose, then 90 mg PO BID for 12 months; long-term post-MI: 60 mg BID |
| preparations | String | 60, 90 mg tablets |
| fda_max | String | 90 mg BID (acute year); 60 mg BID (chronic post-MI) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | Antiplatelet effect within 30 minutes of loading dose (faster than clopidogrel) |
| duration | String | 12 hours |
| halflife | String | ~7 hours (parent); ~9 hours (active AR-C124910XX metabolite, accounts for ~30-40% of activity)'"`UNIQ--ref-00000C92-QINU`"' |
| bioavailability | String | ~36% (oral)'"`UNIQ--ref-00000C93-QINU`"' |
| pregnancy | String | Limited data; weigh against alternatives.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US. Carries a '''Boxed Warning''' for bleeding risk and against aspirin maintenance doses above 100 mg/d (reduces ticagrelor efficacy, per PLATO subgroup analysis)'"`UNIQ--ref-00000C94-QINU`"' |